普通胰岛素与诺和锐治疗糖尿病酮症酸中毒的治疗效果

Therapeutic Effect of Common Insulin and Nuoherui on the Treatment of Diabetic Ketoacidosis

目的研究坦白酮症酸中毒患者接受普通胰岛素与诺和锐治疗的效果,给临床治疗提供参考。方法 2016年1—8月对该院的糖尿病酮症酸中毒患者80例进行了分析研究,将患者分成了对照组和观察组,均有40例,对照组患者接受普通胰岛素治疗,观察组患者接受诺和锐治疗,对两组治疗一段时间的情况进行观察组分析。结果治疗一段时间,诺和锐治疗的患者后期胰岛素使用了量平均是(88.6±11.2)U,普通胰岛素治疗的患者平均胰岛素使用量是(432.5±15.3)U,患者体内的症状缓解较快,胰岛素水平和尿酮水平经过治疗能够快速恢复,24 h的血糖变化情况显示,观察组患者的血糖水平比较稳定,低血糖发生次数差异有统计学意义(P<0.05)。结论糖尿病酮症酸中毒患者接受诺和锐治疗的效果比较好,能够让患者的病情得到缓解,临床中可以进行推广使用。

Objective To study the effect of treatment of common insulin and Nuoherui in patients with frankosteric acidosis, and to provide reference for clinical treatment. Methods From January to August 2016, 80 patients with diabetic ketoacidosis in the hospital were analyzed. The patients were divided into the control group and the observation group. With 40 patients in each group. The patients in the control group received general insulin therapy. The patients in the observation group received Nuoherui treatment, and observe analyze the treatment of the two groups for a period of time. Results After treatment for a period of time, the average insulin intake in patients treated with Nuoherui was （88.6±11.2）U, and the average insulin use in patients treated with ordinary insulin was （432.5±15.3）U. The symptoms in patients were relieved faster. Insulin level and urinary ketone level can be quickly recovered after treatment. The 24-hour blood glucose changes showed that the blood glucose level of the observation group was stable and the number of hypoglycemia was statistically different （P〈0.05）. Conclusion Patients with diabetic ketoacidosis receive the effect of Nuoherui treatment, which can relieve the patient＇s condition and can be promoted and used in clinical practice.